Karen L. Smith Insider Trading $SGMO SANGAMO THERAPEUTICS, INC
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Karen L. Smith.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Karen L. Smith. Karen L. Smith is Director in ANTARES PHARMA, INC. ($ATRS) and Director in SANGAMO THERAPEUTICS, INC ($SGMO) and EVP, R&D and CMO in Jazz Pharmaceuticals plc ($JAZZ) and Global Head of R&D and CMO in Jazz Pharmaceuticals plc ($JAZZ) and Director in ACCELERON PHARMA INC ($XLRN) and Director in Sucampo Pharmaceuticals, Inc. ($SCMP) and EVP, Chief Medical Officer in Emergent BioSolutions Inc. ($EBS).
Karen L. Smith in SANGAMO THERAPEUTICS, INC
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Karen L. Smith: Director
Holdings: 25,700 shares
Current Value: $98,945
Latest Transaction: Mar 01 2021
$SGMO Market Capitalization: $254.24M
$SGMO Previous Close: $3.85
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Karen L. Smith in SANGAMO THERAPEUTICS, INC
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, XLRN, ATRS, EBS, JAZZ, SGMO, SCMP
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 01 2021 | SGMO | SANGAMO THERAPEUTI ... | Smith Karen L. | Director | Option Exercise | A | 11.19 | 16,400 | 183,516 | 16,400 | |
| Mar 01 2021 | SGMO | SANGAMO THERAPEUTI ... | Smith Karen L. | Director | Grant | A | 0.00 | 8,200 | 0 | 25,700 | 17.5 K to 25.7 K (+46.86 %) |
| May 20 2020 | SGMO | SANGAMO THERAPEUTI ... | Smith Karen L. | Director | Option Exercise | A | 10.46 | 15,000 | 156,900 | 15,000 | |
| May 20 2020 | SGMO | SANGAMO THERAPEUTI ... | Smith Karen L. | Director | Grant | A | 0.00 | 2,500 | 0 | 10,000 | 7.5 K to 10 K (+33.33 %) |
| Jun 12 2019 | SGMO | SANGAMO THERAPEUTI ... | Smith Karen L. | Director | Option Exercise | A | 9.38 | 15,000 | 140,700 | 15,000 | |
| Jun 12 2019 | SGMO | SANGAMO THERAPEUTI ... | Smith Karen L. | Director | Grant | A | 0.00 | 2,500 | 0 | 7,500 | 5 K to 7.5 K (+50.00 %) |
| Jun 28 2018 | SGMO | SANGAMO THERAPEUTI ... | Smith Karen L. | Director | Option Exercise | A | 15.65 | 30,000 | 469,500 | 30,000 | |
| Jun 28 2018 | SGMO | SANGAMO THERAPEUTI ... | Smith Karen L. | Director | Grant | A | 0.00 | 5,000 | 0 | 5,000 | 0 to 5 K |
Page: 1